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a b s t r a c t
Arsenic (+ 3 oxidation state) methyltransferase (As3mt) catalyzes reactions which convert inorganic arsenic
to methylated metabolites. This study determined whether the As3mt null genotype in the mouse modiﬁes
cytotoxic and proliferative effects seen in urinary bladders of wild type mice after exposure to inorganic
arsenic. Female wild type C57BL/6 mice and As3mt KO mice were divided into 3 groups each (n = 8) with
free access to a diet containing 0, 100 or 150 ppm of arsenic as arsenite (AsIII). During the ﬁrst week of AsIII
exposure, As3mt KO mice exhibited severe and lethal systemic toxicity. At termination, urinary bladders of
both As3mt KO and wild type mice showed hyperplasia by light microscopy. As expected, arsenic-containing
granules were found in the superﬁcial urothelial layer of wild type mice. In As3mt KO mice these granules
were present in all layers of the bladder epithelium and were more abundant and larger than in wild type
mice. Scanning electron microscopy of the bladder urothelium of As3mt KO mice treated with 100 ppm AsIII
showed extensive superﬁcial necrosis and hyperplastic changes. In As3mt KO mice, livers showed severe
acute inﬂammatory changes and spleen size and lymphoid areas were decreased compared with wild type
mice. Thus, diminished arsenic methylation in As3mt KO mice exacerbates systemic toxicity and the effects of
AsIII on the bladder epithelium, showing that altered kinetic and dynamic behavior of arsenic can affect its
toxicity.
© 2010 Elsevier Inc. All rights reserved.

Introduction
Inorganic arsenic is a known human carcinogen affecting urinary
bladder, skin, and lung, with principle exposure from drinking water
(National Research Council Subcommittee on Arsenic in Drinking
Water, 1999, 2001). Inorganic arsenic exists mainly in the environment as trivalent arsenite (iAsIII) or pentavalent arsenate (iAsV)
(National Research Council Subcommittee on Arsenic in Drinking
Water, 1999, 2001). Ingested inorganic arsenic undergoes reactions in
which it is alternately reduced from pentavalency to trivalency, and
trivalent arsenicals are oxidatively methylated to yield mono-, di-, and
tri- methylated metabolites (Thomas et al., 2007). Although this
methylation pathway has long been regarded as a detoxiﬁcation
process (Vahter, 1983), some intermediates formed during the

⁎ Corresponding author. Fax: +402 559 9297.
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methylation process (e.g.,. monomethylarsonous acid (MMAIII) and
dimethylarsinous acid (DMAIII)) are highly reactive and more
cytotoxic in vitro than iAsIII (Petrick et al., 2000; Styblo et al., 2000;
Cohen et al., 2002). Hence, the methylation pathway can also be
described as an activation process that may be responsible for some of
the toxic and carcinogenic effects commonly associated with
exposure to inorganic As (Le et al., 2000; Thomas et al., 2001). In
addition, metabolism of arsenic also involves conversion of methylated oxy-arsenicals to corresponding methylated thio-arsenicals. For
example, dimethylmonothioarsinic acid (DMMTAV ) has been
detected in urine of humans exposed to high levels of inorganic
arsenic in the drinking water (Raml et al., 2007) and in urine of
arsenite (AsIII)-treated rats in a study in our laboratory (Suzuki et al.,
2010). Methylated thio-arsenicals that contain pentavalent arsenic
may be more toxic than the corresponding methylated oxy-arsenicals
that contain pentavalent arsenic. In our laboratory, in vitro studies
found the LC50 for DMMTAV in MYP3 rat urothelial cells to be 1.34 µM
which is closer to the toxicity of trivalent non-thiolated arsenicals

0041-008X/$ – see front matter © 2010 Elsevier Inc. All rights reserved.
doi:10.1016/j.taap.2010.04.013

This article is a U.S. government work, and is not subject to copyright in the United States.

2

M. Yokohira et al. / Toxicology and Applied Pharmacology 246 (2010) 1–7

such as arsenite (0.75 µM) and DMAIII (0.38 µM) than to pentavalent
non-thiolated arsenicals such as monomethylarsonic acid (3.0 mM)
and dimethylarsinic acid (0.66 mM). The unanticipated toxicity of
methylated thio-arsenicals that contain pentavalent arsenic could
depend on facile transport across cell membranes or on ease of
conversion to methylated oxy-arsenicals that contain trivalent arsenic
(Suzuki et al., 2010). Taken together, it is clear that the conversion of
inorganic arsenic to methylated oxy-arsenicals and corresponding
methylated thio-arsenicals is likely to be a critical determinant of
toxic and carcinogenic effects associated with exposure to inorganic
arsenic.
In short-term studies (1–10 weeks), we have recently found that
treatment of mice with high concentrations of arsenic administered as
sodium arsenite (NaAsIII) in the diet induced hyperplasia in the
bladder epithelium (Lin et al., 2007; Suzuki et al., 2008b). We
hypothesized that reactive methylated arsenicals produced during
metabolism of inorganic arsenic bind to sulfhydryl groups of critical
cellular proteins in the urinary bladder epithelium, leading to
urothelial cytotoxicity and regenerative proliferation and, eventually,
to tumors. Because the cytosolic enzyme, arsenic (+3 oxidation state)
methyltransferase (As3mt) catalyzes reactions involved in the
reduction and oxidative methylation of arsenicals (Thomas et al.,
2007; 2010; Hester et al., 2009), it was of interest to determine the
effects of inorganic arsenic exposure in a mouse with a null genotype
for As3mt. Initial studies in an As3mt knockout (As3mt KO) mouse
found that inhibition of arsenic methylation resulted in altered tissue
distribution and clearance of arsenic (Drobna et al., 2009). In the
current study, we examined the effect of iAsIII treatment on the
urinary bladder epithelium in As3mt KO mice and in wild type mice in
which the capacity of enzymatically catalyzed methylation of arsenic
was intact. The As3mt null genotype was found to potentiate the
effects of inorganic arsenic exposure on the urinary bladder
epithelium, suggesting that the formation of methylated metabolites
of inorganic arsenic was not required for cytotoxicity in this target
tissue.
Materials and methods
Chemicals. NaAsIII (AsNaO2, anhydrous) was purchased from Sigma
(St. Louis, MO) and was used as received without additional analysis.
The purity stated by Sigma was 99%. NaAsIII was stored desiccated at
room temperature.
As3mt KO mice. Two male and four female mice homozygous for the
disrupted As3mt gene (Drobna et al., 2009) were obtained from Dr.
David Thomas (U.S. EPA, Research Triangle Park, NC). The homozygous As3mt KO mice were developed by deletion of exons 3 through 5
of the As3mt gene after homologous recombination. The altered gene
was introduced and maintained in strain 129S6 mice and then
introduced into strain C57BL/6 mice by marker-assisted accelerated
backcrossing performed by Charles River Laboratories (Wilmington,
MA) to produce homozygous As3mt−/− mice. The As3mt KO mice are
fertile so brother/sister matings were used to maintain the homozygous As3mt knockouts.
Upon arrival, animals were placed in quarantine and housed on
aspen wood shavings in polycarbonate cages with micro-isolator tops
in a HEPA ﬁltered, ﬂexible ﬁlm isolator in a quarantine facility
accredited by the American Association for Accreditation of Laboratory Animal Care (AAALAC) at the University of Nebraska Medical
Center. The isolator was targeted at a temperature of 22 °C and
relative humidity of 50% and on a 12 h light/dark schedule (0600/
1800 CST). Mice were provided with diet (irradiated Teklad 2018S
with Fenbendazole, Harlan Teklad, Madison WI) and hyperchlorinated (b10 ppm chlorine) reverse osmosis (RO) water ad libitum.
After release from quarantine, mice were moved to the transgenic
area of an AAALAC-accredited facility with the targeted environmen-

tal conditions listed above. Mice were provided autoclaved, pelleted
Teklad 7012 diet (Harlan Teklad, Madison, WI) and housed on dry
corncob bedding with Nestlets™ and mouse houses added for
environmental enrichment. During mating, up to two females were
housed with one male. Once pregnancy was noted, the female was
separated from the male and singly housed. Pups were weaned
21 days or later following birth and group housed (5 or fewer
animals/cage) based on dam and sex.
Animal experiment.
Twenty-four female wild type C57BL/6 mice
(Charles River Breeding Laboratories, Raleigh, NC) 7 weeks old at the
time of arrival, were placed in an AAALAC-accredited facility and
quarantined for 12 days prior to treatment. Twenty-four As3mt KO
mice from the F2 generation, approximately 7 weeks old, were
transferred from the breeding colony to the same room. The level of
care provided to the animals met or exceeded the basic requirements
outlined in the Guide for the Care and Use of Laboratory Animals (NIH
Publication #86-23, revised 1986). All animals were housed in
polycarbonate cages (4/cage) with micro-isolator tops and dry
corncob bedding. Nestlets™ were added to the cage for environmental enrichment. The animal room was targeted at 22 °C and 50%
humidity and on a 12 h light/dark schedule (0600/1800 CST). Mice
were provided with pelleted Purina 5002 (Dyets Inc., Bethlehem, PA)
and hyperchlorinated (b10 ppm chlorine) reverse osmosis (RO)
water ad libitum.
At approximately 8 weeks of age, animals were randomized into 3
treatment groups per genotype (8/group) using a weight stratiﬁcation method (Martin et al., 1986) and started on treatment diets. For
each genotype, group 1 was treated with the basal diet, group 2 was
treated with diet containing 173 ppm NaAsIII (100 ppm AsIII) and
group 3 was treated with diet containing 260 ppm NaAsIII (150 ppm
AsIII). Diets were mixed and pelleted by Dyets Inc. (Bethlehem, PA).
Acute toxicity was observed in As3mt KO mice treated with 100 and
150 ppm AsIII. Seven mice in the As3mt KO group treated with
150 ppm AsIII died before termination and therefore, the remaining
As3mt KO mouse and all wild type mice in the 150 ppm AsIII groups
were terminated on study day 7. Also on study day 7, the dose in the
100 ppm AsIII As3mt KO and wild type groups was reduced to 50 ppm
AsIII (86.5 ppm NaAsIII) and the route of administration was changed
to the drinking water. This necessitated a change from RO water to tap
water for all remaining mice. Body weights of all animals were
measured the day after arrival, prior to randomization, and on study
days 0 and 7. Body weights were also measured on the majority of
animals terminated on study day 9, and on surviving animals on study
day 14.
Because of the perilous clinical status of AsIII-treated As3mt KO
mice, all remaining animals were terminated on study days 9 and 15.
The animals terminated on the various study days are shown in
Table 1. At termination, the urinary bladder was inﬂated in situ with
Bouin's ﬁxative, and after removal, the bladders were placed in
Bouin's ﬁxative. A small section of intestine was removed and placed
in Bouin's with the bladder. Following ﬁxation, the Bouin's-ﬁxed
bladders and intestinal tissue were rinsed in 70% ethanol, the bladders
were weighed, and all tissues were observed macroscopically. The
entire surface of one half of the bladder was examined by scanning
electron microscopy (SEM) and classiﬁed in one of ﬁve categories as
previously described (Cohen et al., 1990). Brieﬂy, class 1 bladders
have polygonal superﬁcial urothelial cells; class 2 bladders have
occasional small foci of superﬁcial urothelial necrosis; class 3 bladders
have numerous small foci of superﬁcial urothelial necrosis; class 4
bladders have extensive superﬁcial urothelial necrosis, especially in
the dome of the bladder; and class 5 bladders have necrosis and piling
up (hyperplasia) of rounded urothelial cells. Normal rodent urinary
bladders are usually class 1 or 2, or occasionally class 3. The other half
of the bladder was cut longitudinally into strips and with a slice of
intestinal tissue was embedded in parafﬁn, stained with hemotoxylin
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Table 1
Morbidity and mortality.
Animal fatea

Mouse
Group

Genotype

Treatment

d6b

d7

d8

d9

d15

1
2
3
4
5
6

As3mt KO
As3mt KO
As3mt KO
Wild type
Wild type
Wild type

Control
100/50 ppm AsIII
150 ppm AsIII
Control
100/50 ppm AsIII
150 ppm AsIII

–
–
4(D)
–
–
–

–
–
3(D), 1(MT)
–
–
8(T)

–
1(D), 1(MT)
–
–
–
–

4(T)
6(MT)
–
–
8(T)
–

4(T)
–
–
8(T)
–
–

a
b

Number of animals (D, Dead; T, terminated; MT, moribund and terminated).
Experimental day.

and eosin (H&E), and examined histopathologically (Cohen, 1983;
Cohen et al., 1990; 2007). A diagnosis of mild simple hyperplasia was
made when there were 4–5 cell layers in the bladder epithelium. The
liver, spleen and kidneys were also removed and weighed, and the
lungs were removed and inﬂated with formalin via the trachea. These
organs were placed in formalin and embedded in parafﬁn, stained
with H&E, and examined histopathologically.
Statistics. The group means for body weights, and tissue weights
were evaluated using analysis of variance followed by the Duncan's
multiple range test for group-wise comparisons. Histopathology was
compared using the 2-tailed, Fisher's exact test. SEM data were analyzed
using 1-way nonparametric procedures followed by a chi square test. P
values less than 0.05 were considered signiﬁcant. These statistical
analyses were performed using SAS for Windows (Version 9.1).
Results
Morbidity and mortality
Four As3mt KO mice treated with 150 ppm AsIII were found dead on
study day 6 and an additional 3 mice in the same group were found dead
on study day 7 (Table 1). The remaining animal in this group was
terminated on study day 7 due to signs of severe acute toxicity. On study
day 8, after reducing the dose in the 100 ppm AsIII group to 50 ppm AsIII
on study day 7, one As3mt KO mouse was found dead and a second
As3mt KO mouse was terminated due to extreme toxicity. On study day
9, the remaining 6 As3mt KO mice in the 100/50 ppm group were
terminated due to severe acute toxicity. Because of autolysis, necropsies
were not performed on animals found dead. Several of the As3mt KO
mice treated with AsIII showed symptoms of acute arsenic poisoning,
including body tremors, decreased activity and an unsteady gait.

Body and tissue weights
Administration of AsIII to As3mt KO mice (groups 2 and 3) caused
severe depression in body weight gain by day 7 (Table 2). In the
150 ppm AsIII As3mt KO group, 7 mice were found dead by day 7, but
the single mouse that could be evaluated for body weight showed a
dramatic loss (13.4 g vs a mean of 18.2 g in the As3mt KO control
mice). Body weights in the As3mt KO 100/50 ppm AsIII group on day 7
showed a signiﬁcant decrease compared with the As3mt KO control
group and the comparable wild type group. Body weights of wild type
mice treated with 150 ppm AsIII also decreased signiﬁcantly on day 7
compared to wild type control mice indicating 150 ppm AsIII
(260 ppm NaAsIII) to be toxic even in wild type mice. However,
none of these mice died or showed signs of acute poisoning. The organ
weights were assessed, using relative weights for comparisons since
the timing of the termination was not the same for all mice.
Macroscopically, the size of the spleen in both As3mt KO and wild
type mice treated with AsIII was small, and the size in As3mt KO mice
treated with AsIII was much smaller than in wild type mice. Relative
weights of spleens were decreased signiﬁcantly in the As3mt KO 100/
50 ppm AsIII group compared with the wild type 100/50 ppm group
by week 2 (Table 3). The weights of the liver, kidney and bladder
showed no signiﬁcant inter-group differences.
Histopathologically, simple hyperplasia of the bladder epithelium
was detected in the single As3mt KO mouse treated with 150 ppm
AsIII that was necropsied, in 3 of 8 wild type mice treated with
150 ppm, and in 3 of 7 As3mt KO mice and 3 of 8 wild type mice in the
100/50 ppm treatment groups (Table 4). Numerous intracytoplasmic
granules were present in the epithelial layer of the bladder in the
As3mt KO and wild type AsIII-treated mice. In wild type mice, the
granules were present mostly in the superﬁcial layer of the
urothelium (Figs. 1E and F). However, in As3mt KO mice treated

Table 2
Body weights of the mice on day 0, 7 and 14.a
Group

Mouse Genotype

Treatment

d0b

d7

d14

1
2
3
4
5
6

As3mt KO
As3mt KO
As3mt KO
Wild type
Wild type
Wild type

Control
100/50 ppm AsIII
150 ppm AsIII
Control
100/50 ppm AsIII
150 ppm AsIII

18.0 ± 0.3(8)
17.4 ± 0.4(8)c
17.6 ± 0.3(8)e
18.2 ± 0.3(8)
18.5 ± 0.2(8)
18.4 ± 0.2(8)

18.2 ± 0.4(8)
15.4 ± 0.4(8)c,d
13.4(1)f
18.5 ± 0.3(8)
18.8 ± 0.2(8)
16.7 ± 0.1(8)g

17.9 ± 0.2(4)
–
–
18.5 ± 0.3(8)
–
–

a
b
c
d
e
f
g

Values expressed as the mean ± S.E. (n) where appropriate.
Experimental days.
Signiﬁcantly different compared to the wild type 100/50 ppm AsIII group, p b 0.05.
Signiﬁcantly different compared to As3mt KO control group, p b 0.05.
Signiﬁcantly different compared to wild type 150 ppm AsIII group, p b 0.05.
No statistical analysis of group performed.
Signiﬁcantly different compared to wild type control group, p b 0.05.
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Table 3
Relative weights of the organs in the mice.a
Mouse
Weekb

Group

1
1
2
2
3
3
a
b
c

3
6
2
5
1
4

Genotype
As3mt KO
Wild type
As3mt KO
Wild type
As3mt KO
Wild type

Treatment
III

150 ppm As
150 ppm AsIII
100/50 ppm AsIII
100/50 ppm AsIII
Control
Control

Body Weight

Bladder

Kidney

Liver

Spleen

(g)

(mg/g BW)

(mg/g BW)

(mg/g BW)

(mg/g BW)

13.4(1)
16.7 ± 0.1(8)
14.0 ± 0.3(6)c
18.4 ± 0.3(8)
17.9 ± 0.2(4)
18.5 ± 0.3(8)

2.48(1)
1.65 ± 0.14(8)
2.13 ± 0.27(6)
2.06 ± 0.15(8)
1.95 ± 0.21(4)
1.87 ± 0.12(8)

17.1(1)
13.4 ± 0.2(8)
16.9 ± 0.2(6)c
13.7 ± 0.3(8)
13.5 ± 0.4(4)
12.4 ± 0.3(8)

50.0(1)
44.0 ± 0.7(8)
51.3 ± 1.7(6)
50.8 ± 1.9(8)
50.4 ± 1.7(4)
50.2 ± 1.7(8)

1.85(1)
2.49 ± 0.07(8)
1.72 ± 0.17(6)c
3.24 ± 0.12(8)
4.27 ± 0.13(4)
3.88 ± 0.14(8)

Values expressed as the mean ± S.E. (n) where appropriate.
The study week termination was performed.
Signiﬁcantly different compared to wild type 100/50 ppm AsIII group, p b 0.05, on week 2.

with AsIII, granules were present in all layers of the urothelium, where
they were plentiful, larger, and appeared to also involve the nucleus
(Figs. 1B and C).
In the lung, liver, spleen, kidneys and intestines, no proliferative
lesions were observed in any group. Livers from AsIII-treated As3mt
KO groups (Figs. 2B and C) showed severe acute inﬂammatory
changes with inﬂammatory cell inﬁltration, increased apoptosis and
cytoplasmic vacuolation. Livers from wild type mice treated with AsIII
(Fig. 2A), showed no histopathologic changes. The white pulp of the
spleen was markedly decreased in the AsIII-treated As3mt KO groups
(Fig. 2E) compared with the AsIII-treated wild type groups (Fig. 2D).
The intestine, kidneys and lungs showed no remarkable changes in
any group.
By SEM, the incidence of class 5 bladders was increased
signiﬁcantly in the As3mt KO mice treated with 100/50 ppm AsIII
compared with the As3mt KO control mice (Fig. 3A) and wild type
mice treated with 100/50 ppm AsIII (Table 4). The bladders of the
As3mt KO mice treated with 100/50 ppm AsIII showed cytotoxicity,
necrosis (Fig. 3B) and pilling up of small round urothelial cells
indicative of proliferation and hyperplasia (Fig. 3C).
Discussion
Characterization of arsenic distribution and retention in the As3mt
KO mouse has shown that, following administration of a single oral
dose of iAsV, there is much diminished formation of methylated
metabolites and that the rate of clearance of arsenic from tissues is
much slower than in wild type mice (Drobna et al., 2009). The reduced
rate of clearance of arsenic in As3mt KO mice demonstrates that the
clearance of arsenic is facilitated by the formation of methylated
metabolites. This ﬁnding is consistent with earlier work suggesting a
critical role for methylation in the clearance of arsenic (Marafante and
Vahter, 1984; Carlson-Lynch et al., 1994). Because of lower rates of
whole body clearance of arsenic and of arsenic methylation, tissue

concentrations of arsenic attained under the continuous exposure
conditions used in this study would be expected to be much higher in
As3mt KO mice than in wild type mice. As a consequence of the higher
retention of arsenic in tissues of iAsIII-treated As3mt KO mice, there
was histopathological evidence of injury in urinary bladder and liver
which are target organs for cancer in humans chronically exposed to
inorganic arsenic in drinking water.
In the present experiment, we demonstrated that this accumulation of arsenic following multiple doses rapidly leads to severe
systemic arsenic toxicity. At a dose of 150 ppm arsenite in the diet,
nearly all of the animals died within the ﬁrst seven days of exposure.
The animals showed clinical signs of severe toxicity including rapid
and severe weight loss, trembling, decreased activity, and unstable
movements, suggesting neurologic toxicity. Furthermore, histopathologically, there was severe damage to the liver, including necrosis
and inﬂammation. There was also suppression of the lymphoid
system, as evidenced by a marked decrease in splenic size, primarily
due to a severe shrinkage of the white pulp (lymphocytes). In the
liver, the histopathologic changes included hepatocellular balloonlike vacuolation, apoptosis and necrosis, and inﬂammatory cell
inﬁltrate. In humans with acute arsenic poisoning, similar changes
are seen in the liver, including the hepatocellular balloon-like
vacuolation, apoptosis, necrosis, and an inﬂammatory inﬁltrate and
ﬁbrosis (Santra et al., 1999; Lu et al., 2001; Mazumder, 2005; Wu et al.,
2008). In addition, there is also endothelial degeneration, and if the
toxicity persists, the inﬂammation can lead to ﬁbrosis and cirrhosis as
well as increased incidence of hepatocellular carcinomas and liver
hemangiosarcomas (Centeno et al., 2002).
Notably, we did not observe toxicity in either the lungs or the
kidney, and there was no grossly observable toxicity in other tissues
besides the liver and spleen. We did not examine the nervous system
histopathologically. Thus, the histopathological evidence of adverse
effects of arsenic exposure was conﬁned to tissues which have been
identiﬁed as sites of tumor initiation in arsenic-exposed humans.

Table 4
The histopathological ﬁndings and SEM classiﬁcation analysis of the mice.
Histopathology
Week
1
1
2
2
2
3
3
a
b
c

a

SEM classiﬁcation

Group

Mouse genotype

Treatment

No. of mice examined

Normal

Simple hyperplasia

1

2

3

4

5

3
6
1
2
5
1
4

As3mt KO
Wild type
As3mt KO
As3mt KO
Wild type
As3mt KO
Wild type

150 ppm AsIII
150 ppm AsIII
Control
100/50 ppm AsIII
100/50 ppm AsIII
Control
Control

1
8
4
7
8
4
8

–
5
4
4
5
4
7

1
3
–
3
3
–
1

–
3
4
–
8
3
4

–
3
–
–
–
–
4

–
2
–
1
–
–
–

–
–
–
–
–
–
–

1
–
–
6b,c
–
–
–

The study week termination was performed.
SEM classiﬁcation signiﬁcantly different compared to the As3mtKO control group, p b 0.05, on week 2.
SEM classiﬁcation signiﬁcantly different compared to the wild type group treated with 100 ppm AsIII, p b 0.05, on week 2.
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Fig. 1. Histopathological ﬁndings of the bladder epithelium. (A, As3mt KO control; B, As3mt KO 100/50 ppm AsIII; C, As3mt KO 150 ppm AsIII; D, wild type control; E, wild type 100/
50 ppm AsIII; F, wild type 150 ppm AsIII). Granules in the epithelial layer of bladders with simple hyperplasia (B, C, E and F). In the AsIII-treated As3mt KO mice, the granules occurred
in all layers of the epithelium (arrows) and in both the cytoplasm and the nucleus (arrow heads) (B and C). Both As3mt KO and wild type control mice showed normal epithelium (A
and D). Magniﬁcation ×400.

In previous work, we have focused on the generation of DMAIII, a
highly reactive metabolite of inorganic arsenic, as a chemical species
that produces cytotoxicity and consequent regenerative proliferation
in the urinary bladder (Cohen et al., 2007; Suzuki et al., 2010). Thus,
we hypothesized that in the As3mt KO mouse, without the formation
of sufﬁcient amounts of a reactive trivalent methylated arsenical (e.g.,
DMAIII), there would be no adverse effect on the urothelium.
However, the current study found clear evidence of cytotoxicity and
regenerative proliferation in the urothelium of As3mt KO and wild
type mouse following treatment with either 150 or 100 ppm iAsIII. It is
difﬁcult to assess the ﬁndings in the As3mt KO mouse at 150 ppm
since we were only able to evaluate 1 mouse bladder in this group
because of the early deaths in the remaining animals. However, at the
dose of 100 ppm, most As3mt KO mice were found to have evidence of
severe cytotoxicity observed by scanning electron microscopy,
frequently in association with evidence of increased proliferation
with hyperplasia (piling up of small round cells). Clearly, in As3mt KO
mice, cytotoxicity with regenerative proliferation of the urothelium
following arsenite administration did not require methylation and the
consequent formation of the highly reactive trivalent methylated
arsenicals. Rather, uroepithelial injury could be the consequence of
the retention of high levels of inorganic arsenic in this tissue in an
animal which neither efﬁciently methylates nor clears arsenic. Effects
on the urothelium in the As3mt KO mice and in the wild type mice are
consistent with previous studies using human urothelial cells
(UROtsa) in vitro which also do not have As3mt activity (Styblo et
al., 2002; Sen et al., 2007).
We have previously reported the presence of numerous intracytoplasmic eosinophilic granules in the superﬁcial cells of the
urothelium of iAsIII-treated mice (Suzuki et al., 2008a), and have
demonstrated that these granules are intramitochondrial and that

they contain large amounts of arsenic in the form of arsenite (Arnold
et al., 2006; Suzuki et al., 2008a; 2008b). In the current study, we
found that these granules were even more pronounced in As3mt KO
mice than in the wild type mice. Furthermore, in the As3mt KO mice,
the granules were bigger, more plentiful, and appeared to involve all
layers of the urothelium (not just the superﬁcial cell layer). The
granules appeared to also accumulate within the nuclei in addition
to the cytoplasm in As3mt KO mice. The abundance and location of
these granules in As3mt KO mice is likely due to the accumulation of
very high concentrations of inorganic arsenic in urothelial cells of
these animals.
The methylated trivalent arsenicals MMAIII and DMAIII are highly
reactive and produce severe cytotoxicity of urothelial cells in vitro at
concentrations that are below 1 μM (Nascimento et al., 2008; Suzuki
et al., 2010). At slightly greater concentrations, approximately 0.8–
1.5 μM, iAsIII is signiﬁcantly cytotoxic. Hence, a relatively modest
decrease in the rate of clearance of inorganic arsenic from urothelial
cells in As3mt KO mouse could be sufﬁcient to increase the
concentration above the threshold for cytotoxicity. Thus, given the
effects of the As3mt null genotype on the distribution and retention of
inorganic arsenic, it is plausible that the genotype could render iAsIII a
potent cytotoxin of urinary bladder cells. The ﬁnding of uroepithelial
cell injury in As3mt KO mice is not inconsistent with earlier results
suggesting that DMAIII is the arsenical responsible for the induction of
cell injury. Rather, the results of the current study suggest that the
combination of low rates of arsenic methylation and of tissue
clearance of inorganic arsenic are sufﬁcient to produce conditions in
which inorganic arsenic can cause cytotoxicity in the urinary bladder.
Based on functions of LC50 concentrations rather than functions
of speciﬁc concentrations, the effects of arsenic in vitro appear to be
additive for the various trivalent arsenicals (Nascimento et al.,
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Fig. 2. Histopathological ﬁndings of the liver and spleen. The livers indicated severe acute inﬂammatory changes with inﬂammatory cell inﬁltration, increasing numbers of apoptotic
cells and vacuolation of the cytoplasm were present in As3mt KO mice treated with 100/50 ppm (B) or 150 ppm AsIII (C). The white pulp of the spleen was markedly decreased in the
As3mt KO 100/50 ppm AsIII group (E) compared with the wild type 100/50 ppm AsIII group (D). Magniﬁcation, liver ×200; magniﬁcation, spleen ×40.

2008). We therefore hypothesize that the speciﬁc biologic effects of
arsenic exposure depend on the toxicokinetic aspects of arsenic
metabolism and distribution combined with the sensitivity of the
targeted cellular constitutions (probably speciﬁc protein sulfhydryl
groups) to the various trivalent forms of arsenic. This likely will vary
between tissues and between species, as well as inter-individual
variation and on conditions of exposure to factors that could
inﬂuence the toxicokinetic and toxicodynamic aspects of arsenic.
Thus, it is likely that the response to exposure to inorganic arsenic is
dependent on the exposure of cells to the combination of trivalent
arsenicals. Additional studies in As3mt KO mice of the disposition
and retention of other intermediates in the pathway for arsenic

methylation should help illuminate the relative potency of these
arsenicals as cytotoxins.
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